IMVT
Immunovant, Inc. · Healthcare
Chief Medical Officer William L. Macias sold $96K of Immunovant, Inc.
Sold$96,274
$29.65Price
3,247Shares
−1%Stake
What IMVT did after the filing
- The stock from Fri, May 24 close, $28.95
- +4.8%
- S&P 500, same days
- +6.4%
Measured over 30 trading days, to the Jul 10 close.
Traded Wed, May 22. Filed Fri, May 24, 12:13 PM ET, during the session. Returns use the May 24 close and the Jul 10 close. Not investment advice.